ClinicalTrials.Veeva

Menu

Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients

M

MeMed

Status

Completed

Conditions

COVID-19

Treatments

Diagnostic Test: IP-10 in CDS protocol

Study type

Observational

Funder types

Industry

Identifiers

NCT04389645
MM-5000-BV

Details and patient eligibility

About

The proposed project will pilot incorporation of rapid serial measurements of IP-10 into a CDS tool for moderate and severe COVID-19 patients.

The tool was applied to all comers with confirmed COVID-19 diagnosis at a secondary medical center in Israel.

Enrollment

52 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • PCR- positive for COVID-19

Exclusion criteria

  • <18 years of age

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems